You have no items in your shopping cart.
Triple Analysis
In this section you will find Publication Series Analytical Tool Triple Analysis market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities in the biotech, life science and pharmaceutical industries.
| Items 1 to 10 of 15 total |
Page:
|
Show per page |
| View as: List Grid |
Sort by
|
Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Breast and Prostate Cancer
Published by BioSeeker Group on Feb 6th, 2008
€ 3,450.00
This is the report for professionals interested to grasp the field of apoptopic drug targets in oncology and at the same time have an extensive R&D overview of breast- and prostate cancer. Learn More
Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Lung Cancer and Melanoma
Published by BioSeeker Group on Feb 6th, 2008
€ 3,450.00
This is the report for professionals interested to grasp the field of apoptopic drug targets in oncology and at the same time have an extensive R&D overview of lung cancer and melanoma. Learn More
Triple Analysis: Decoding Big Pharmas R&D Strategy in Oncology and Special Focus Lung Cancer and Melanoma
Published by BioSeeker Group on Sep 14th, 2007
€ 3,450.00
This is the report for professionals interested to grasp big pharma’s R&D strategy in oncology and at the same time have an extensive R&D overview of the lung cancer and melanoma field. Learn More
Triple Analysis: Decoding Big Pharmas R&D Strategy In Oncology and Special Focus on Breast and Prostate Cancer
Published by BioSeeker Group on Sep 14th, 2007
€ 3,450.00
This is the report for professionals interested to grasp big pharma’s R&D strategy in oncology and at the same time have an extensive R&D overview of the breast- and prostate cancer field. Learn More
Triple Analysis: Decoding Big Pharmas R&D Strategy in Oncology and Special Focus on Leukemias and Lymphomas
Published by BioSeeker Group on Sep 14th, 2007
€ 3,450.00
This is the report for professionals interested to grasp big pharma’s R&D strategy in oncology and at the same time have an extensive R&D overview of the leukemia and lymphoma field. Learn More
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Melanoma and NSCLC
Published by BioSeeker Group on Jul 19th, 2007
€ 3,450.00
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug targets, Melanoma, and NSCLC, which are all subjects to an extensive number of innovative drug candidates. Learn More
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Leukemias and Lymphomas
Published by BioSeeker Group on Jun 12th, 2007
€ 3,450.00
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug targets, Leukemias and Lymphomas, which are all subjects to an extensive number of innovative drug candidates. Learn More
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Breast- and Prostate Cancer
Published by BioSeeker Group on Jun 11th, 2007
€ 3,450.00
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug targets, Breast- and Prostate Cancer, which are all subjects to an extensive number of innovative drug candidates. Learn More
Triple Analysis: Apoptosis Agents, Antibodies and Vaccines in Oncology
Published by BioSeeker Group on Dec 19th, 2006
€ 3,450.00
This extensive 350+ pages report compiles and analyzes in parallel the progress concerning drug development and competitive situation in the three mentioned key oncology areas. Learn More
Triple Analysis: Apoptosis Agents, Protein Kinase Inhibitors and Anti-Angiogenic Agents in Oncology
Published by BioSeeker Group on Dec 19th, 2006
€ 3,450.00
This extensive 345+ pages report compiles and analyzes in parallel the progress concerning drug development and competitive situation in the three key oncology areas: Apoptotic agents, Protein Kinase Inhibitors and Anti-Angiogenic agents. Learn More
| Items 1 to 10 of 15 total |
Page:
|
Show per page |
| View as: List Grid |
Sort by
|